4.8 Article

Dynamic risk profiling of HCC recurrence after curative intent liver resection

期刊

HEPATOLOGY
卷 76, 期 5, 页码 1291-1301

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.32411

关键词

-

向作者/读者索取更多资源

We evaluated the natural progression, pattern, and timing of various disease states after liver resection for HCC using multistate modeling and created a practical calculator to provide prognostic information for patients and clinicians.
Background and Aims Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians. Approach and Results Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post-LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence-free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease-free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post-LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on . Conclusions In contrast to standard single time-to-event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Surgery

Should Cell Salvage Be Used in Liver Resection and Transplantation? A Systematic Review and Meta-analysis

Luckshi Rajendran, Tori Lenet, Risa Shorr, Jad Abou Khalil, Kimberly A. Berten, Fady K. Balaa, Guillaume Martel

Summary: Objective of this study was to evaluate the effect of intraoperative blood cell salvage and autotransfusion (IBSA) use on red blood cell (RBC) transfusion and postoperative outcomes in liver surgery. The results showed that IBSA may reduce intraoperative allogeneic RBC transfusion without compromising oncologic outcomes, but the current evidence base is limited in size and quality, and high-quality randomized controlled trials are needed.

ANNALS OF SURGERY (2023)

Article Surgery

Long-term outcomes of retransplantation after live donor liver transplantation: A Western experience

Tommy Ivanics, Ashley Limkemann, Madhukar S. Patel, Marco P. A. W. Claasen, Luckshi Rajendran, Woo Jin Choi, Chaya Shwaartz, Nazia Selzner, Les Lilly, Mamatha Bhat, Cynthia Tsien, Markus Selzner, Ian McGilvray, Blayne Sayed, Trevor Reichman, Mark Cattral, Anand Ghanekar, Gonzalo Sapisochin

Summary: Despite the increase in living donor liver transplants, the outcomes of retransplantation after living donor liver transplant need further investigation. This study compared the waitlist outcomes and survival post-retransplant in recipients of initial living or deceased donor grafts. The results showed similar waitlist mortality and survival rates for both types of transplants.

SURGERY (2023)

Article Surgery

Machine learning-based mortality prediction models using national liver transplantation registries are feasible but have limited utility across countries

Tommy Ivanics, Delvin So, Marco P. A. W. Claasen, David Wallace, Madhukar S. Patel, Annabel Gravely, Woo Jin Choi, Chaya Shwaartz, Kate Walker, Lauren Erdman, Gonzalo Sapisochin

Summary: Many countries have national registries of liver transplant data, which are used to generate predictive models. However, the performance and transferability of these models are unclear. This study developed machine learning algorithm-based models using data from 3 national registries to predict 90-day post-transplant mortality and evaluated the predictive performance and external validity of each model.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Surgery

Lymphopenia at the time of transplant is associated with short-term mortality after deceased donor liver transplantation

Toshihiro Kitajima, Luckshi Rajendran, Eric Lisznyai, Mei Lu, Tayseer Shamaa, Tommy Ivanics, Atsushi Yoshida, Marco P. A. W. Claasen, Marwan S. Abouljoud, Gonzalo Sapisochin, Shunji Nagai

Summary: The absolute lymphocyte count (ALC) is a surrogate marker for nutritional status and immunocompetence. This study investigates the association between ALC and post-liver transplant outcomes in deceased donor liver transplant (DDLT) patients. The results show that patients with low ALC have higher 180-day mortality, as well as increased incidence of bacteremia and cytomegaloviremia.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Editorial Material Oncology

ASO Author Reflections: Viral Hepatitis on Post-Hepatectomy Outcomes in the Direct-Acting Antivirals Era

Luckshi Rajendran, Woo Jin Choi, Gonzalo Sapisochin

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals

Luckshi Rajendran, Woo Jin Choi, Hala Muaddi, Tommy Ivanics, Jordan J. Feld, Marco P. A. W. Claasen, Matthew Castelo, Gonzalo Sapisochin

Summary: This study suggests that viral hepatitis status is not associated with 30-day post-hepatectomy complications, major complications, or PHLF in patients with HCC.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: The Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals

Luckshi Rajendran, Woo Jin Choi, Hala Muaddi, Tommy Ivanics, Jordan J. Feld, Marco P. A. W. Claasen, Matthew Castelo, Gonzalo Sapisochin

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma

Marco P. A. W. Claasen, Tommy Ivanics, Berend R. Beumer, Roeland F. de Wilde, Wojciech G. Polak, Gonzalo Sapisochin, Jan N. M. IJzermans

Summary: This study evaluated the management of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) through an online survey sent to expert centres. The results showed that liver resection is considered the first-line treatment for cHCC-CCA, but there are significant differences in treatment decisions among different specialties and regions. Therefore, a multicentre prospective trial is needed to compare different treatments and optimize the therapeutic management of cHCC-CCA.

JHEP REPORTS (2023)

Meeting Abstract Surgery

Era-Specific Improvements in Age-Disparate Outcomes After Liver Transplantation forAcute Liver Failure: A Population-Based Analysis of the United Kingdom and Ireland

T. Ivanics, D. Wallace, M. M. Claasen, M. Rizzari, M. Abouljoud, A. Yoshida, S. Nagai, W. Bernal

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Surgery

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma

Marco Petrus Adrianus Wilhelmus Claasen, Dimitri Sneiders, Yannick Sebastiaan Rakke, Rene Adam, Sherrie Bhoori, Umberto Cillo, Constantino Fondevila, Maria Reig, Gonzalo Sapisochin, Parissa Tabrizian, Christian Toso

Summary: Liver transplantation offers the best chance of cure for most non-metastatic hepatocellular carcinoma patients. Downstaging and bridging therapies, such as ablation and transarterial chemoembolization, can be used to lower the patient's condition and keep them within transplant criteria. Immunotherapy shows great potential in supporting downstaging and bridging therapies.

TRANSPLANT INTERNATIONAL (2023)

Letter Surgery

Red blood cell transfusions in liver surgery

Tori Lenet, Laura Baker, Michael Vered, Aklile Workneh, Amin Zahrai, Luckshi Rajendran, Jad Abou-Khalil, Fady K. Balaa, Kimberly A. Bertens, Daniel I. McIsaac, Alan Tinmouth, Dean A. Fergusson, Guillaume Martel

BRITISH JOURNAL OF SURGERY (2023)

Article Oncology

Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma

Shingo Shimada, Tayseer Shamaa, Tommy Ivanics, Toshihiro Kitajima, Mohamed Adhnan, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan Abouljoud, Reena Salgia, Shunji Nagai

Summary: This study investigated the impact of pre-transplant treatment for hepatocellular carcinoma (HCC) on the risk of posttransplant recurrence. The results showed that pretreatment reduced the risk of recurrence, and patients who achieved pathologically complete response (pCR) had a lower risk of recurrence. Furthermore, multiple treatments were associated with a higher risk of post-transplant recurrence.

ANNALS OF SURGICAL ONCOLOGY (2023)

暂无数据